Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants

Veterinary Immunology and Immunopathology

Volumn 151, Issue 3-4, 2013, Pages 315-324

  Aguirreburualde, María Sol Pérez ^a   Gómez, María Cristina ^b   Ostachuk, Agustín ^a   Wolman, Federico ^c   Albanesi, Guillermo ^c   Pecora, Andrea ^a   Odeon, Anselmo ^d   Ardila, Fernando ^b   Escribano, José M ^e   Santos, María José Dus ^a   Wigdorovitz, Andrés ^a  

^a CICVyA   (Argentina)

^b CICVyA   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d EEA Balcarce INTA   (Argentina)

^e INIA   (Spain)

Author keywords

Bovine viral diarrhea virus; Subunit vaccine; Transgenic plants

Indexed keywords

BOVINE VIRAL DIARRHEA VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE;

ALFALFA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BOVINE VIRAL DIARRHEA; COW; DRUG EFFICACY; FEMALE; GUINEA PIG; IMMUNIZATION; MALE; NONHUMAN; PLANT LEAF; TRANSGENIC PLANT;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUS 1, BOVINE VIRAL; FEMALE; GUINEA PIGS; MALE; MEDICAGO SATIVA; PLANTS, GENETICALLY MODIFIED; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME; VACCINATION; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; CAVIA; MEDICAGO SATIVA;

EID: 84872768875     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.12.004     Document Type: Article

References (52)

1. Ashraf S., Singh P.K., Yadav D.K., Shahnawaz M., Mishra S., Sawant S.V., Tuli R. High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J. Biotechnol. 2005, 119:1-14.
2. Aviezer D., Brill-Almon E., Shaaltiel Y., Hashmueli S., Bartfeld D., Mizrachi S., Liberman Y., Freeman A., Zimran A., Galun E. A plant-derived recombinant human glucocerebrosidase enzyme - a preclinical and phase I investigation. PLoS ONE 2009, 4:e4792.
3. Baker J.C. The clinical manifestations of bovine viral diarrhea infection. Vet. Clin. North Am. Food Anim. Pract. 1995, 11:425-445.
4. Bolin S.R. Control of bovine viral diarrhea infection by use of vaccination. Vet. Clin. North Am. Food Anim. Pract. 1995, 11:615-625.
5. Chia M.Y., Hsiao S.H., Chan H.T., Do Y.Y., Huang P.L., Chang H.W., Tsai Y.C., Lin C.M., Pang V.F., Jeng C.R. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant. Vet. Immunol. Immunopathol. 2010, 135:234-242.
6. Chia M.Y., Hsiao S.H., Chan H.T., Do Y.Y., Huang P.L., Chang H.W., Tsai Y.C., Lin C.M., Pang V.F., Jeng C.R. Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs. Vet. Immunol. Immunopathol. 2011, 140:215-225.
7. Daniell H., Singh N.D., Mason H., Streatfield S.J. Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci. 2009, 14:669-679.
8. Daniell H., Streatfield S.J., Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 2001, 6:219-226.
9. Denecke J., Botterman J., Deblaere R. Protein secretion in plant cells can occur via a default pathway. Plant Cell 1990, 2:51-59.
10. Deregt D., van Rijn P.A., Wiens T.Y., van den Hurk J. Monoclonal antibodies to the E2 protein of a new genotype (type 2) of bovine viral diarrhea virus define three antigenic domains involved in neutralization. Virus Res. 1998, 57:171-181.
11. Deutskens F., Lamp B., Riedel C.M., Wentz E., Lochnit G., Doll K., Thiel H.J., Rumenapf T. Vaccine-induced antibodies linked to bovine neonatal pancytopenia (BNP) recognize cattle major histocompatibility complex class I (MHC I). Vet. Res. 2011, 42:97.
12. Dong J.L., Liang B.G., Jin Y.S., Zhang W.J., Wang T. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection. Virology 2005, 339:153-163.
13. Drakakaki G., Marcel S., Arcalis E., Altmann F., Gonzalez-Melendi P., Fischer R., Christou P., Stoger E. The intracellular fate of a recombinant protein is tissue dependent. Plant Physiol. 2006, 141:578-586.
14. Dus Santos M.J., Carrillo C., Ardila F., Rios R.D., Franzone P., Piccone M.E., Wigdorovitz A., Borca M.V. Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine 2005, 23:1838-1843.
15. Dus Santos M.J., Wigdorovitz A., Trono K., Rios R.D., Franzone P.M., Gil F., Moreno J., Carrillo C., Escribano J.M., Borca M.V. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 2002, 20:1141-1147.
16. Fernandez F., Costantini V., Barrandeguy M., Parreno V., Schiappacassi G., Maliandi F., Leunda M., Odeon A. Evaluation of experimental vaccines for bovine viral diarrhea in bovines, ovines and guinea pigs. Rev. Argent. Microbiol. 2009, 41:86-91.
17. Ferrer F., Zoth S.C., Calamante G., Taboga O. Induction of virus-neutralizing antibodies by immunization with Rachiplusia nu per os infected with a recombinant baculovirus expressing the E2 glycoprotein of bovine viral diarrhea virus. J. Virol. Methods 2007, 146:424-427.
18. Floss D.M., Falkenburg D., Conrad U. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res. 2007, 16:315-332.
19. Fulton R.W., Saliki J.T., Burge L.J., d'Offay J.M., Bolin S.R., Maes R.K., Baker J.C., Frey M.L. Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay. Clin. Diagn. Lab. Immunol. 1997, 4:380-383.
20. Gil F., Perez-Filgueira M., Barderas M.G., Pastor-Vargas C., Alonso C., Vivanco F., Escribano J.M. Targeting antigens to an invariant epitope of the MHC Class II DR molecule potentiates the immune response to subunit vaccines. Virus Res. 2011, 155:55-60.
21. Gomord V., Fitchette A.C., Menu-Bouaouiche L., Saint-Jore-Dupas C., Plasson C., Michaud D., Faye L. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol. J. 2010, 8:564-587.
22. Karnoup A.S., Turkelson V., Anderson W.H. O-linked glycosylation in maize-expressed human IgA1. Glycobiology 2005, 15:965-981.
23. Koya V., Moayeri M., Leppla S.H., Daniell H. Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect. Immun. 2005, 73:8266-8274.
24. Kweon C.H., Yoon Y.D., An S.H., Lee Y.S. Expression of envelope protein (E2) of bovine viral diarrhea virus in insect cells. J. Vet. Med. Sci. 1997, 59:415-419.
25. Legocki A.B., Miedzinska K., Czaplinska M., Plucieniczak A., Wedrychowicz H. Immunoprotective properties of transgenic plants expressing E2 glycoprotein from CSFV and cysteine protease from Fasciola hepatica. Vaccine 2005, 23:1844-1846.
26. Marzocca M.P., Seki C., Giambiagi S.M., Robiolo B., Schauer R., Dus Santos M.J., Scodeller E.A., La Torre J.L., Wigdorovitz A., Grigera P.R. Truncated E2 of bovine viral diarrhea virus (BVDV) expressed in Drosophila melanogaster cells: a candidate antigen for a BVDV ELISA. J. Virol. Methods 2007, 144:49-56.
27. Mason H.S., Lam D.M., Arntzen C.J. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:11745-11749.
28. McCormick A.A., Reddy S., Reinl S.J., Cameron T.I., Czerwinkski D.K., Vojdani F., Hanley K.M., Garger S.J., White E.L., Novak J., Barrett J., Holtz R.B., Tuse D., Levy R. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10131-10136.
29. McKersie B.D., Chen Y., de Beus M., Bowley S.R., Bowler C., Inze D., D'Halluin K., Botterman J. Superoxide dismutase enhances tolerance of freezing stress in transgenic alfalfa (Medicago sativa L.). Plant Physiol. 1993, 103:1155-1163.
30. Moravec T., Schmidt M.A., Herman E.M., Woodford-Thomas T. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine 2007, 25:1647-1657.
31. Nelson G., Marconi P., Periolo O., La Torre J., Alvarez M.A. Immunocompetent truncated E2 glycoprotein of bovine viral diarrhea virus (BVDV) expressed in Nicotiana tabacum plants: a candidate antigen for new generation of veterinary vaccines. Vaccine 2012, 30:4499-4504.
32. Nemchinov L.G., Paape M.J., Sohn E.J., Bannerman D.D., Zarlenga D.S., Hammond R.W. Bovine CD14 receptor produced in plants reduces severity of intramammary bacterial infection. FASEB J. 2006, 20:1345-1351.
33. Nochi T., Takagi H., Yuki Y., Yang L., Masumura T., Mejima M., Nakanishi U., Matsumura A., Uozumi A., Hiroi T., Morita S., Tanaka K., Takaiwa F., Kiyono H. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10986-10991.
34. Odeon A.C., Leunda M.R., Faverin C., Boynak N., Vena M.M., Zabal O. In vitro amplification of BVDV field strains isolated in Argentina: effect of cell line and culture conditions. Rev. Argent. Microbiol. 2009, 41:79-85.
35. Ostachuk A., Chiavenna S., Gómez C., Pecora A., Pérez-Filgueira M., Escribano J.M., Ardila F., Dus Santos M.J., Wigdorovitz A. Expression of a ScFv-E2T fusion protein in CHO-K1 cells and alfalfa transgenic plants for the selective directioning to antigen presenting cells. Vet. Immunol. Immunopathol. 2009, 315.
36. Oszvald M., Kang T.J., Tomoskozi S., Jenes B., Kim T.G., Cha Y.S., Tamas L., Yang M.S. Expression of cholera toxin B subunit in transgenic rice endosperm. Mol. Biotechnol. 2008, 40:261-268.
37. Paton D.J., Lowings J.P., Barrett A.D. Epitope mapping of the gp53 envelope protein of bovine viral diarrhea virus. Virology 1992, 190:763-772.
38. Pecora A., Aguirreburualde M.S., Aguirreburualde A., Leunda M.R., Odeon A., Chiavenna S., Bochoeyer D., Spitteler M., Filippi J.L., Dus Santos M.J., Levy S.M., Wigdorovitz A. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle. Vet. Res. Commun. 2012, 36:157-164.
39. Pecora A., Perez Aguirreburualde M.S., Rodriguez D., Seki C., Levy M.S., Bochoeyer D., Dus Santos M.J., Wigdorovitz A. Development and validation of an ELISA for quantitation of bovine viral diarrhea virus antigen in the critical stages of vaccine production. J. Virol. Methods 2009, 162:170-178.
40. Pellerin C., van den Hurk J., Lecomte J., Tussen P. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 1994, 203:260-268.
41. Perez Filgueira D.M., Mozgovoj M., Wigdorovitz A., Dus Santos M.J., Parreno V., Trono K., Fernandez F.M., Carrillo C., Babiuk L.A., Morris T.J., Borca M.V. Passive protection to bovine rotavirus (BRV) infection induced by a BRV VP8* produced in plants using a TMV-based vector. Arch. Virol. 2004, 149:2337-2348.
42. Rosas C.T., Konig P., Beer M., Dubovi E.J., Tischer B.K., Osterrieder N. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. J. Gen. Virol. 2007, 88:748-757.
43. Rybicki E.P. Plant-made vaccines for humans and animals. Plant Biotechnol. J. 2009, 8:620-637.
44. Samac D.A., Tesfaye M., Dornbusch M., Saruul P., Temple S.J. A comparison of constitutive promoters for expression of transgenes in alfalfa (Medicago sativa). Transgenic Res. 2004, 13:349-361.
45. Shams H. Recent developments in veterinary vaccinology. Vet. J. 2005, 170:289-299.
46. Stanic M. A simplification of the estimation of the 50 percent endpoints according to the Reed and Muench method. Pathol. Microbiol. (Basel) 1963, 26:298-302.
47. Thiel H.J., Plagemann P.G.W., Moennig V. Pestiviruses. Virology 1996, 1059-1073. Lippincott-Raven, PA. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
48. Thomas C., Young N.J., Heaney J., Collins M.E., Brownlie J. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus. Vaccine 2009, 27:2387-2393.
49. Tiwari S., Verma P.C., Singh P.K., Tuli R. Plants as bioreactors for the production of vaccine antigens. Biotechnol. Adv. 2009, 27:449-467.
50. Wigdorovitz A., Carrillo C., Dus Santos M.J., Trono K., Peralta A., Gomez M.C., Rios R.D., Franzone P.M., Sadir A.M., Escribano J.M., Borca M.V. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 1999, 255:347-353.
51. Yonekura-Sakakibara K., Saito K. Review: genetically modified plants for the promotion of human health. Biotechnol. Lett. 2006, 28:1983-1991.
52. Zhang X., Buehner N.A., Hutson A.M., Estes M.K., Mason H.S. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol. J. 2006, 4:419-432.